Field of Science

Review on N-methylation

Veteran peptide chemist Horst Kessler (TU Munich) has a good review on the effects of N-methylation of peptides and proteins in a recent issue of Angewandte Chemie. N-methylation has been an interesting and frequently productive strategy for a long time, but the main problem was that the chemistry needed to implement it wasn't there yet. But thanks to new developments chemists have caught up and selective N-methylation of amides no longer needs to be the rate-limiting step that it was.

N-methylation has a variety of interesting and potentially very useful effects on small molecule and peptide conformation and function. For one thing, N-methylated amide bonds have a different distribution of cis and trans forms which is somewhat more evenly distributed than that in non N-methylated amide bonds which dominantly prefer the trans conformation. This can significantly tweak the distribution of conformations in solution.

From a biological standpoint things get even more interesting. N-methylation makes the molecule more lipophilic and therefore more membrane-permeable, improving cell penetration. It gets rid of one hydrogen bonding N-H bond. This can sometimes have an unfavorable effect on permeability if that N-H forms an intramolecular hydrogen bond, but often it can help. Intramolecular hydrogen bonds are another valuable tactic for hiding polar surface area and improving permeability. The ideal situation is a combination of both N-methylation and intramolecular hydrogen bonding, exemplified by the archetypal "large", complex, biologically active drug, cyclosporine. Recent studies by the Jacobson (UCSF) and Lokey (groups) have described strategies for both specific N-methylation chemistry and for predicting permeability using computational calculations.

Finally, N-methylation can prevent recognition and cleavage by peptidases which recognize "normal" amide bonds, especially when the N-methylated amides are part of a cyclic peptide. All these factors can significantly improve bioavailability. Kessler talks about all of them and illustrates these principles with a few striking examples, including somatostatin, amanitin and melanocortin. Many of these sport similar motifs, leading to ideas for possible design of standardized building blocks for improving permeability and bioavailability. The piece is worth a look if you are into developing peptides and peptidomimetics as drugs or even more generally if you are interested in peptide and small molecule conformations.

The value of long-term vision


Friend and fellow blogger David Kroll has a great profile of Bob Lefkowitz, last year's chemistry Nobel Laureate from Duke. The most striking thing for me was to read about how Duke bent over backwards and went to unbelievable lengths to get Lefkowitz on their faculty in the 70s. Says something about the value of long-term vision and investment in basic research, something that sadly seems to be exceedingly lacking these days.

"Lefkowitz almost didn't make it to Duke. He had already committed to practicing medicine at the Massachusetts General Hospital of Harvard University after his service commitment. After six months there, "I really missed the lab," Lefkowitz recalls, adding he was "like a junkie who needed a fix."
Meanwhile, 600 miles south in Durham, the medical school at Duke University was flourishing. Dr. Andy Wallace, chief of cardiology, had seen the young Lefkowitz present his receptor studies at an American Heart Association meeting. He and Dr. Jim Wyngaarden, chairman of medicine, they tried to lure Lefkowitz to Duke. However, Harvard had already promised Lefkowitz a faculty position after his cardiology fellowship.
Lefkowitz admits he had no intention of coming to Duke and politely rejected Duke's offer. But Wallace and Wyngaarden rejected Lefkowitz's rejection. Their counteroffer included a $32,000 annual salary—the equivalent of $165,000 today (the initial offer was $24,000)—and an open-ended request for his other needs.
Still thinking Duke wasn't in his future, he responded with "outrageous demands" Lefkowitz says. One of those was that he start as an associate professor with academic tenure, a position that requires rigorous review at seven to 11 years of faculty service. He was just 30, straight out of his fellowship.
"That was the most outrageous demand and that was the one put in there to scotch the whole deal because I didn't want to come," Lefkowitz says. "The whole purpose of my request was to give me a graceful way out because I knew in my head that what I was asking was impossible."
Wyngaarden and Wallace met every demand.
Lefkowitz was dumbfounded. "Duke was a young institution [in 1973]. But it was a decent institution, and the offer was just so non-comparable with what Harvard was offering that I said, 'This is it. I gotta go for it.'"
"But a lot of people said, 'How can you go to Duke?' Even my in-laws at the time." He reproduces the Yiddish accent: "'Whaddaya, crazy? You're at Hawvaad.' But something said, 'Go for this.'"

Who knew VCs had a sense of humor

So it's the annual J P Morgan Healthcare Conference in California and I see, of all things...#jpmpickuplines on Twitter. I don't know how much these can mitigate the still-dour VC landscape, but hey, at least nobody can blame them for trying to present evidence that they are human.


Chemistry and Biology: Kuhnian or Galisonian?


Peter Galison who has emphasized the dominance of experimental techniques in engineering scientific revolutions (Image: BNL).
First published on the Scientific American Blog Network.

Freeman Dyson has a perspective in this week's Science magazine in which he provides a summary of a theme he has explored in his book "The Sun, the Genome and the Internet". Dyson's central thesis is that scientific revolutions are driven as much or even more by tools than by ideas. This view runs somewhat contrary to the generally accepted belief regarding the dominance of Kuhnian revolutions - described famously by Thomas Kuhn in his seminal book "The Structure of Scientific Revolutions" - which are engineered by ideas and shifting paradigms. In contrast, in reference to Harvard university historian of science Peter Galison and his book "Image and Logic", Dyson emphasizes the importance of Galisonian revolutions which are driven mainly by experimental tools.

As a chemist I find myself in almost complete agreement with the idea of tool-driven Galisonian revolutions. Chemistry as a discipline rose from the ashes of alchemy, a thoroughly experimental activity. Since then there have been four revolutions in chemistry that can be called Kuhnian. One was the attempt by Lavoisier, Priestley and others at the turn of the 17th century to systematize elements, compounds and mixtures to separate chemistry from the shackles of alchemical mystique. The second was the synthesis of urea by Friedrich Wohler in 1828; this was a paradigm shift in the true sense of the term since it placed substances from living organisms into the same realm as those from non-living organisms. The third revolution was the conception of the periodic table by Mendeleev, although this was more of a classification akin to the classification of elementary particles by Murray Gell-Mann and others during the 1960s. A minor revolution accompanying Mendeleev's invention that was paramount for organic chemistry was the development of the structural theory by von Leibig, Kekule and others which led the way to structure determination of molecules. The fourth revolution was the application of quantum mechanics to chemistry and the elucidation of the chemical bond by Pauling, Slater, Mulliken and others. All these advances blazed new trails, but none were as instrumental or overarching as the corresponding revolutions in physics by Newton (mechanics), Carnot, Clausius and others (thermodynamics), Maxwell and Faraday (electromagnetism), Einstein (relativity) and Einstein, Planck and others (quantum mechanics).

Why does chemistry seem more Galisonian and physics seem more Kuhnian? One point that Dyson does not allude to but which I think is cogent concerns the complexity of the science. Physics can be very hard, but chemistry is more complex in that it deals with multilayered, emergent systems that cannot yield themselves to reductionist, first principles approaches. This kind of complexity is also apparent in the branches of physics typically subsumed under the title of "many-body interactions". Many-body interactions range from the behavior of particles in a superconductor to the behavior of stars condensing into galaxies under the influence of their mutual gravitational interaction. There are of course highly developed theoretical frameworks to describe both kinds of interactions, but they involve several approximations and simplifications, resulting in models rather than theories. My contention is that the explanation of more complex systems, being less amenable to theorizing, are driven by Galisonian revolutions rather than Kuhnian.

Chemistry is a good case in point. Linus Pauling's chemical theory arose from the quantum mechanical treatment of molecules, and more specifically the theory of the simplest molecule, the hydrogen molecular ion which consists of one electron interacting with two nuclei. The parent atom, hydrogen, is the starting point for the discipline of quantum chemistry. Open any quantum chemistry textbook and what follows from this simple system is a series of approximations that allow one to apply quantum mechanics to complex molecules. Today quantum chemistry and more generally theoretical chemistry are highly refined techniques that allow one to explain and often predict the behavior of molecules with hundreds of atoms.

And yet if you look at the insights gained into molecular structure and bonding over the past century, they have come from a handful of key experimental approaches. Foremost among these are x-ray diffraction, which Dyson also mentions, and Nuclear Magnetic Resonance (NMR) spectroscopy, also the basis of MRI. It is hard to overstate the impact that these techniques have had on the determination of the structure of literally millions of molecules ranging across an astonishing range of diversity, from table salt to the ribosome. X-ray diffraction and NMR have provided us not only with the locations of the atoms in a molecule, but also with invaluable insights into the bonding and energetic features of the arrangements. Along with other key spectroscopic methods like infrared spectroscopy, neutron diffraction and fluorescence spectroscopy, x-rays and magnetic resonance have not just revolutionized the practice of chemical science but have also led to the most complete understanding we have yet of chemical bonding. Contrast this wealth of data with similar attempts using purely theoretical techniques which can also be used in principle to predict the structures, properties and functions of molecules. Progress in this area has been remarkable and promising, but it's still orders of magnitude harder to predict, say, the most stable configuration of a simple molecule in a crystal than to actually crystallize the chemical even by trial and error. From materials for solar cells to those for organ transplants, experimental structure determination in chemistry has fast outpaced theoretical prediction.

What about biology? The Galisonian approach in the form of x-ray diffraction and NMR has been spectacularly successful in the application of chemistry to biological systems that culminated in the advent of molecular biology in the twentieth century. Starting with Watson and Crick's solution of the structure of DNA, x-ray diffraction basically helped formulate the theory of nucleic acid and protein structure. Particularly noteworthy is the Sanger method of gene sequencing - an essentially chemical technique - which has had a profound and truly revolutionary impact on genetics and medicine that we are only beginning to appreciate. Yet we are still far from a theory of protein structure in the form of protein folding; that Kuhnian revolution is yet to come. The dominance of Galisonian approaches to biochemistry raise the question about the validity of Kuhnian thinking in the biological sciences. This is an especially relevant question because the last Kuhnian revolution in biology - a synthesis of known facts leading to a general explanatory theory that could encapsulate all of biology - was engineered by Charles Darwin more than 150 years ago. Since then nothing comparable has happened in biological science; as indicated earlier, the theoretical understanding of the genetic code and the central dogma came from experiment rather than the very general synthesis in terms of replicators, variation and fitness that Darwin put together for living organisms. Interestingly, in his later years (and only a year before the discovery of the structure of DNA) the great mathematician John von Neumann put forward a Darwin-like, general theoretical framework that explained how replication and metabolism could be coupled to each other, but this was largely neglected and certainly did not come to the attention of practicing chemists and biologists.

Dyson's essay and the history of science does not necessarily assert that the view of science in terms of Kuhnian revolutions is misguided and that in terms of Galisonian revolutions is justified. It's rather that complex systems are often more prone to Galisonian advances because the theoretical explanations are simply too complicated. Another viewpoint driven home by Dyson is that Kuhnian and Galisonian approaches alternate and build on each other. It is very likely that after a few Galisonian spells a field becomes ripe for a Kuhnian consolidation.
Biology is going to be especially interesting in this regard. 

The most exciting areas in current biology are considered to be neuroscience, systems biology and genomics. These fields have been built up from an enormous number of experimentally determined facts but they are in search of general theories. However, it is very likely that a general theoretical understanding of the cell or the brain will come from very different approaches from the reductionist approaches that were so astonishingly successful in the last two hundred years. A Kuhnian revolution to understand biology could likely borrow from its most illustrious practitioner - Charles Darwin. One of the signature features of Darwin's theory is that it seeks to provide a unified understanding that transcends multiple levels of biological organization, from individual to society. Our twenty-first view of biology adds two pieces, genes and culture, to opposite ends of the ladder. It is time to integrate these pieces - obtained by hard, creative Galisonian science - into the Kuhnian edifice of biology.

Nobel Week Dialogue

There hasn't been much blogging over the last two weeks, mainly because I have been blogging for a special event preceding the official Nobel Prize ceremony in Stockholm. 

"Nobel Week Dialogue" was a day-long symposium organized by the Nobel committee and other sponsors on December 9. The topic was "The Genomic Revolution and its Impact on Society" and it featured many science and policy leaders including Eric Lander, Steven Chu, James Watson and Craig Mello. 

I was invited to write for this event and I have four posts, mainly historical and philosophical, contemplating aspects of the genomic revolution.

Why the same can be different: The case of the two enantiomers

The R enantiomer (green) allows Tyr337 to adopt
two different orientations. The S (yellow) does not.
Since we were discussing thermodynamics in biological systems the other day, here's a neat example from Angewandte Chemie of a system where thermodynamics reveals something surprising. The authors from UmeÃ¥ University in Sweden were looking at two enantiomers of a ligand binding acetylcholinesterase. It's a robust, well-studied system and you don't really expect anything unexpected.

Except that it does do something unexpected. The first surprise was that both enantiomers bound with the same binding affinity. This is an observation that violates a central general tenet of biochemistry, namely that ligands and receptors are both chiral and therefore enantiomeric ligands will bind differently. The second surprise was that when they dissected the similar free energy of binding into entropic and enthalpic components, they found that the S enantiomer had a much more unfavorable entropy (1.5 e.u) than the R (8.5 e.u). Since the free energies were the same, this meant that there was enthalpy-entropy compensation, which meant in turn that the S enantiomer must have the more favorable enthalpy.

To investigate the origins of these differences, the two enantiomers were crystallized with the protein. Observation of the binding site indicated something interesting; the R enantiomer bound in a way that allowed a critical tyrosine residue (Tyr337) to adopt two different orientations. However, the S enantiomer shoved an ethyl group next to the tyrosine, essentially precluding this movement. Greater conformational flexibility for the tyrosine translated to greater disorder, hence the more favorable entropy for the R. What about enthalpy? Here it turns out that the S enantiomer, while sacrificing entropic freedom for the tyrosine, compensates by making stronger interactions with it. This was analyzed by quantum chemical calculations on a "reduced" version of the protein. Interestingly, the interactions are not "normal", respectable hydrogen bonds but "unnatural" C-H---O hydrogen bonds. For the R enantiomer, even these relatively weak interactions were enough to confer an enthalpic advantage that offset the entropic disadvantage.

This is why chemistry in general and biochemistry in particular are endlessly interesting; conventional wisdom is always being challenged even in well-studied systems, weak can be important, every example is unique and best of all, surprises lurk around almost every corner. As Arthur Kornberg put it, "I never met a dull enzyme".

Angewandte Chemie retracts hexacyclinol paper. Sort of


So it seems that the infamous hexacyclinol saga has been finally put to rest and Angewandte Chemie has retracted the paper. For those chemists who might still be unfamiliar with it, it's not hard to explain: Total synthesis paper published in 2006 with more holes than the vacuum of deep space. Multiple blog postings and papers demolish the claim within months. Journal does not retract the paper for six years.

Well, now the journal has published the retraction. Here's what it has to say:


The following article from Angewandte Chemie International Edition, “Total Syntheses of Hexacyclinol, 5-epi-Hexacyclinol, and Desoxohexacyclinol Unveil an Antimalarial Prodrug Motif” by James J. La Clair, published online on February 9, 2006 in Wiley Online Library (http://onlinelibrary.wiley.com), has been retracted by agreement between the author, the journal Editor in Chief, Peter Gölitz, and Wiley-VCH Verlag GmbH & Co. KGaA. The retraction has been agreed due to lack of sufficient Supporting Information. In particular, the lack of experimental procedures and characterization data for the synthetic intermediates as well as copies of salient NMR spectra prevents validation of the synthetic claims. The author acknowledges this shortcoming and its potential impact on the community.


What I find disappointing about this retraction is that it's just not strong enough in denouncing the paper. It's not just that the procedures were irreproducible or that the supporting information was incomplete, it's that the whole synthesis was essentially...make believe. This was made clear by papers published later (re-synthesizing the natural product and calculating and comparing NMR spectra) which demonstrated beyond any shade of reasonable doubt that whatever was supposedly synthesized in the paper simply couldn't correspond to the structure of hexacyclinol as we know it. 

I think this is an important difference that the retraction does not acknowledge; it's the difference between saying "we think this could be wrong but we can't be sure since we can't reproduce the data" and "we are almost certain this is wrong since independent studies have convincingly demonstrated its utter implausibility".

Update: Carmen Drahl from C&EN has a superb Storify summary of the hexacyclinol saga over the last six years which features some of the blog posts commenting on the debacle. Carmen was also kind enough to post a picture of my cherished hexacyclinol t-shirt which I am still eager to break out; as I said in my email to her, I am still waiting to wear it at a big party where fellow t-shirters get together, laugh with sadistic glee, and mock the scattered bones of hexacyclinol's atomic constituents.

Occam, me and a conformational medley

Originally posted on the Scientific American Blog Network.


William of Occam, whose principle of parsimony has been used and misused (Image: WikiCommons)
The philosopher and writer Jim Holt who has written the sparkling new book “Why Does The World Exist?” recently wrote an op-ed column in the New York Times, gently reprimanding physicists to stop being ‘churlish’ and appreciate the centuries-old interplay between physics and philosophy. Holt’s point was that science and philosophy have always co-existed, even if their relationship has been more of an uneasy truce rather than an enthusiastic embrace. Some of the greatest physicists including Bohr and Einstein were also great philosophers.

Fortunately – or unfortunately – chemistry has had little to say about philosophy compared to physics. Chemistry is essentially an experimental science and for the longest time, theoretical chemistry had much less to contribute to chemistry than theoretical physics had to physics. This is now changing; people like Michael Weisberg, Eric Scerri and Roald Hoffmann proclaim themselves to to be bonafide philosophers of chemistry and bring valuable ideas to the discussion.

But the interplay between chemistry and philosophy is a topic for another post. In this post I want to explore one of the very few philosophical principles that chemists have embraced so wholeheartedly that they speak of it with the same familiar nonchalance with which they would toss around facts about acids and bases. This principle is Occam’s Razor, a sort of guiding vehicle that allows chemists to pick between competing explanations for a phenomenon or observation. Occam’s Razor owes its provenance to William of Occam, a 14th century Franciscan friar who dabbled in many branches of science and philosophy. Fully stated, the proposition tells us that “entities should not be multiplied unnecessarily” or that the fewer the assumptions and hypotheses underlying a particular analysis, the more preferred that analysis relative to those of equal explanatory power. More simply put, simple explanations are always better than complex explanations.

Sadly, the multiple derivate restatements of Occam’s Razor combined with our tendency to look for simple explanations can sometimes lead to erroneous results. Part of the blame lies not with Occam’s razor but with his interpreters; the main problem is that it’s not clear what “simple” and “complex” mean when applied to a natural law or phenomena. In addition, nature does not really care about what we perceive as simple or complex, and what may seem complex to us may appear perfectly simple to nature because it’s…real. This was driven home to me early on in my career.

Most of my research in graduate school was concerned with finding out the many conformations that complex organic molecules adopt in solution. Throw an organic molecule like ibuprofen in water and you don’t get a static picture of the molecule standing still; instead, there is free rotation about single bonds joining various atoms leading to multiple, rapidly interconverting shapes, or conformations, that are buffeted around by water like ships on the high seas. The exact percentage of each conformation in this dance is dictated by its energy; low-energy conformations are more prevalent than high-energy ones.
Different shapes of conformations of cyclohexane - a ring of six carbon atoms - ranked by energy (Image: Mcat review)

Since the existence of multiple conformations enabled by rotation around single bonds is a logical consequence of the basic principles of molecular structure, it would seem that this picture would be uncontroversial. Surprisingly though, it’s not always appreciated. The reason has to do with the fact that measurements of conformations by experimental techniques like nuclear magnetic resonance (NMR) spectroscopy always result in averages. This is because the time-scales for most of these techniques are longer than the time-scales needed for interconversion between conformations and therefore they cannot make out individual differences. The best analogy is that of a ceiling fan; when the fan is rotating fast, all we see is a contiguous disk because of the low time resolution of our eye. But we know that in reality, there are separate individual blades (see figure at end of post). NMR is like the eye that sees the disk and mistakes it for the fan.

Such is the problem with using experimental techniques to determine individual conformations of molecules. Their long time scales lead to average data to which a single, average structure is assigned. Clearly this is a flawed interpretation, but partly because of entrenched beliefs and partly because of lack of methods to tease apart individual conformations, scientists through the years have routinely published single structures as representing a more complex distribution of conformers. Such structures are sometimes called “virtual structures”, a moniker that reflects their illusory – essentially non-existent – nature. A lot of my work in graduate school was to use a method called NAMFIS (NMR Analysis of Molecular Flexibility In Solution) that combined average NMR data with theoretically calculated conformations to tease apart the data into individual conformations. There are others. Here's an article on NAMFIS that I wrote for college students.

When time came to give a talk on this research, a very distinguished scientist in the audience told me that he found it hard to digest this complicated picture of multiple conformations vying for a spot on the energy ladder. Wouldn’t the assumption of a single, clean, average structure be more pleasing? Wouldn’t Occam’s Razor favor this interpretation of the data? That was when I realized the limitations of Occam’s principle. The “complicated” picture of the multiple conformations was the real one in this case, and the simple picture of  a single average conformation was unreal. In this case, it was the complicated and not the simple explanation that turned out to be the right one. This interpretation was validated when I also managed to find, among the panoply of conformations, one which bound to a crucial protein in the body and turned the molecule into a promising anticancer drug. The experience again drove home the point that nature doesn’t often care about what we scientists find simple or complex.

Recently Occam made another appearance, again in the context of molecular conformations. This time I was studying the diffusion of organic molecules through cell membranes, a process that’s of great significance in drug discovery since even your best test-tube drug is useless if it cannot get into a cell. A chemist from San Francisco has come up with a method to calculate different conformations of molecules. By looking at the lowest-energy conformation, he then predicts whether that conformation will be stable inside the lipid-rich cell membrane. Based on this he predicts whether the molecule will make it across. Now for me this posed a conundrum and I found myself in the shoes of my old inquisitor; we know that molecules have several conformations, so how can only the single, lowest-energy conformation matter in predicting membrane permeability?

I still don’t know the answer, but a couple of months ago another researcher did a more realistic calculation in which she did take all these other conformations into consideration. Her conclusion? More often than not the accuracy of the prediction becomes worse because by including more conformations, we are also including more noise. Someday perhaps we can take all those conformations into account without the accompanying noise. Would we then be both more predictive and more realistic? I don’t know.

These episodes from my own research underscores the rather complex and subtle nature of Occam’s Razor and its incarnation in scientific models. In the first case, the assumption of multiple conformations is both realistic and predictive. In the second, the assumption of multiple conformations is realistic but not predictive because the multiple-conformation model is not good enough for calculation. In the first case, a simple application of Occam’s razor is flawed while in the second, the flawed simple assumption actually leads to better predictions. Thus, sometimes simple assumptions can work not because the more complex ones are wrong, but because we simply lack the capacity to implement the more complex ones.

I am glad that my work with molecular conformations invariably led me to explore the quirky manifestations of Occam’s razor. And I am thankful to a well-known biochemist who put it best: “Nature doesn’t always shave with Occam’s Razor”. In science as in life, simple can be quite complicated, and complicated can turn out to be refreshingly simple.

A rotating ceiling fan - Occam's razor might lead us to think that the fan is a contiguous disk, but we know better.

Does modern day college and graduate education in chemistry sacrifice rigor for flexibility?

This is what I love about blogging; it's the classic "one thing leads to another" device. The previous discussion on the paucity of thermodynamics in college coursework led to a more general and important exchange in the comments section that basically asked: Are we sacrificing rigor for flexibility by giving students too much freedom to pick and choose their courses?

The following sentiments (or variations thereof) were expressed:

- There should be a core curriculum for chemistry students that exposes them to mandatory courses in general, organic and physical chemistry at the very least. These requirements seems to be more widespread among physics departments. To my knowledge, Caltech is one of the few schools with a general core curriculum for all science majors. How many other schools have this?

- Part of the lack of exposure to important topics in grad school results from emphasizing research at the cost of coursework. And this is related to a more widespread sentiment of woe: it's become all too easy to get a PhD, partly because of the curse of academia that encourages one to become a glorified technician at the cost of instilling creative scientific thought. The belief is that many professors (and there's many exceptions) would rather produce well-trained manual laborers who contribute to the Grant and Paper Production Factory than independent scientific thinkers who can assimilate ideas from diverse scientific fields. You shouldn't really get a Ph.D. just for putting in 80-hour weeks.

We need to hold students to higher standards, but I think this is not going to happen until the publish-or-perish culture is fundamentally transformed and the movers and shakers of academic research take a hard look at what they are doing to their graduate students.

- Many textbooks are mired in the age-old, classical presentation of thermodynamics that emphasizes Carnot cycles and Maxwell relations much more than any semi-quantative feel for the operation of thermodynamic in practical chemical and biological systems. We are just not doing a good job communicating the real-world importance of topics like thermodynamics; add to this students who are not going to study something if it's not required and we are in a real bind.

- Physical organic chemistry - the one discipline that can naturally build bridges between physical and organic chemistry - is disappearing from the curriculum. Those who intellectually matured in its heyday were naturally exposed to thermodynamics and kinetics. Graduate students in organic chemistry shouldn't be able to get away with just synthesis and spectroscopy courses.

- Matt who, unlike most of us armchair philosophers, is a live professor at an actual research institution, makes the point that we should do an outstanding job of emphasizing thermodynamics in the freshman general chemistry class. We should do such a good job that students should always be able to connect those concepts to anything else that they study later. As Matt recommends, we could include the more qualitative important real-life applications of thermodynamics (and not just to antiquated heat engines) like those in drug discovery in this gen chem class.

All great points in my opinion. I have strong feelings about all this myself, but I have not done any detailed study of college curricula so my opinions are mostly anecdotal. Feel free to chime in with actual data or more opinions in the comments section.

Who's afraid of Big Bad Thermodynamics?

George Whitesides, in a trademark outfit.
In a talk at Northeastern University yesterday, George Whitesides asked the students in the audience if they had ever studied thermodynamics. Not a single hand went up.

Even accounting for the fact that some students might have been reluctant to flag themselves in a large audience, I find this staggering, especially if these students are planning to go into basic drug discovery research. But I can’t completely blame them. I happened to take one (mandatory) thermodynamics and one (non-mandatory) basic statistical mechanics class in college and was exposed to thermodynamics in graduate school through my work on conformational equilibria and NMR. But most of my fellow graduate students in organic and biochemistry had little inkling of thermodynamics; it certainly wasn't a part of their standard intellectual toolkit.

The problem’s made worse by misunderstandings about thermodynamics that seem to linger in students’ heads even later in their career. These misunderstandings stem from a larger rift between organic and physical chemistry; the latter is supposed to be highly mathematical and abstract and rather irrelevant to the former. This is in spite of the overwhelming importance of concepts from p-chem in classical physical organic chemistry. Sadly, classical physical organic chemistry itself is disappearing from the college and grad school curriculum, and an argument in favor of emphasizing thermodynamics is also a plug for not letting physical organic chemistry become a relic of the past. No other topic gives you as good a basic feel for structure, function and reactivity in organic chemistry.

But coming back to thermodynamics, this impression that many students have about thermodynamics being all about Maxwell relations and Carnot cycles and virial theorems is rather misleading. It’s not that these things are not important, it’s just that that’s not the kind of thermodynamics Whitesides was talking about when he was talking about drug discovery. Thermodynamics in drug discovery is often much less complicated than bonafide textbook thermodynamics. And it’s of foundational importance in the field since at its core, drug discovery is about understanding molecular recognition which is completely a thermodynamic phenomenon governed by free energy.

For a drug designer, the key thermodynamic circus to understand is the interplay between G, H, and S as manifested in the classic equation ∆G = ∆H – T∆S. It’s key to get a feel for how opposing values of H and S can lead to the same value of G, since this is at the heart of protein-drug recognition. It’s also important to know the different features of water, protein and solvent that contribute to changes in these parameters. Probably the most important thermodynamic effect that drug designers need to be aware of is the hydrophobic effect. They need to know that the hydrophobic effect is largely an entropic effect arising from the release of bound waters, although as Whitesides has himself demonstrated, reality can be more complicated. But the fact is that we simply cannot understand water without thermodynamics, and we cannot understand drug action without understanding water.

Also paramount is to understand the relationship between thermodynamics and kinetics, something that again benefits from studying reactions under thermodynamic and kinetic control and things like the Curtin-Hammet principle in classical physical organic chemistry. It’s crucial to know the difference between thermodynamic and kinetic stability, especially when one is dealing with small molecule and protein conformations. Finally, it’s enormously valuable to have a feel for a few key numbers, foremost among which may be the relationship between equilibrium constant and free energy; knowing this tells you for instance that it takes only a difference of 1.8 kcal/mol of free energy between two conformers to almost completely shift the conformational equilibrium on to the side of the more stable one. And when that difference is 3 kcal/mol, the higher-energy conformation is all gone, well beyond the detection limits of techniques like NMR. Speaking of which, a good understanding of thermodynamics also tells you why it’s incorrect to rely on average NMR data to tease apart the details of multiple conformations in solution.

All this knowledge about thermodynamics is ingrained more easily than complicated mathematical derivations of configuration integrals in free-energy perturbation theory. Students need to realize that the thermodynamics that they need to tackle drug discovery is a semi-quantitative blend of ideas relying much more on a rough feel for numbers and competing entropic and enthalpic effects. This kind of feel can lead to some very useful insights, for instance regarding relationships between G, H and S in the evolution of new drugs.

It’s time to incorporate this more general thermodynamics outlook in drug discovery classes and even in regular chemistry classes. It’s simple enough to be taught to undergraduates and bypasses the more sophisticated and intimidating ideas of statistical mechanics.

In yesterday’s conference, the chairman had the last laugh. Half-jokingly he emphasized that Northeastern’s chemistry course is ACS certified, which means that one semester of p-chem and thermodynamics are mandatory. Apparently Harvard’s is not. To which Whitesides replied that he can guarantee that you will find students at Harvard who are also not familiar with thermodynamics.

Whitesides's appeal to give pharmaceutical scientists-in-training a firm grounding in thermodynamics applies across the board. On top of Plato’s Academy there was rumored to be a sign which said “Let no one ignorant of geometry enter”. Perhaps one can make a similar case for thermodynamics in the pharmaceutical industry?

Note: 

I have often written about thermodynamics in drug design on my blog. A few potentially useful posts:


Some useful references:

George Whitesides - Designing ligands to bind tightly to proteins (book chapter PDF): Includes much of the material from Whitesides's talk.
Jonathan Chaires - Calorimetry and Thermodynamics in Drug Design.